Page last updated: 2024-12-04

arsenous acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arsenous acid : An arsenic oxoacid consisting of three hydroxy groups attached to a central arsenic atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID545
CHEMBL ID1236189
CHEBI ID49900
MeSH IDM0102035

Synonyms (31)

Synonym
unii-935xd1l5k2
935xd1l5k2 ,
CHEMBL1236189
arsenous oxide anhydride
arsenic (white)
arsenic oxide (3)
arsenic sesquioxide (as2o3)
arsenious oxide, 99.999%
arsorous acid
trihydroxyarsenite(iii)
diarsonic trioxide
arsenic (iii) trioxide
as(oh)3
arsenous trioxide
arsenous acid
DB04456
arsenic trihydroxide
13464-58-9
CHEBI:49900 ,
[as(oh)3]
trihydroxidoarsenic
trioxoarsenic acid
trihydrogen trioxoarsenate(3-)
h3aso3
arsenious acid (h3aso3)
arsenous acid (h3aso3)
DTXSID7074828
aarsenite (aso33-)
arsenous acid ion(3-)
Q423271
rubidium dihydroorthoarsenate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Reactions occurring at ferric oxyhydroxide surfaces play an important role in controlling arsenic bioavailability and mobility in natural aqueous systems."( Density functional theory characterization of the structures of H
de Leeuw, NH; Dzade, NY, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
arsenic oxoacid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Acute myeloid leukemia09

Bioassays (2)

Assay IDTitleYearJournalArticle
AID678983TP_TRANSPORTER: Western blot, HepG2 cells2002Toxicology, Feb-28, Volume: 171, Issue:2-3
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
AID678984TP_TRANSPORTER: RT-PCR in HepG2 cells2002Toxicology, Feb-28, Volume: 171, Issue:2-3
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's0 (0.00)18.2507
2000's6 (23.08)29.6817
2010's12 (46.15)24.3611
2020's5 (19.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.64 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index69.33 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.70%)5.53%
Reviews3 (11.11%)6.00%
Case Studies1 (3.70%)4.05%
Observational0 (0.00%)0.25%
Other22 (81.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]